BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9537257)

  • 21. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization.
    Boukerche H; Su ZZ; Kang DC; Fisher PB
    Gene; 2004 Dec; 343(1):191-201. PubMed ID: 15563845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.
    Neef R; Kuske MA; Pröls E; Johnson JP
    Cancer Res; 2002 Oct; 62(20):5920-9. PubMed ID: 12384558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress.
    Baldi A; Lombardi D; Russo P; Palescandolo E; De Luca A; Santini D; Baldi F; Rossiello L; Dell'Anna ML; Mastrofrancesco A; Maresca V; Flori E; Natali PG; Picardo M; Paggi MG
    Clin Cancer Res; 2005 May; 11(9):3175-83. PubMed ID: 15867210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
    J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
    Pollock PM; Cohen-Solal K; Sood R; Namkoong J; Martino JJ; Koganti A; Zhu H; Robbins C; Makalowska I; Shin SS; Marin Y; Roberts KG; Yudt LM; Chen A; Cheng J; Incao A; Pinkett HW; Graham CL; Dunn K; Crespo-Carbone SM; Mackason KR; Ryan KB; Sinsimer D; Goydos J; Reuhl KR; Eckhaus M; Meltzer PS; Pavan WJ; Trent JM; Chen S
    Nat Genet; 2003 May; 34(1):108-12. PubMed ID: 12704387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of variants of melanoma-associated antigen genes and mRNA transcripts in melanomas of dogs.
    Stell AJ; Dobson JM; Scase TJ; Catchpole B
    Am J Vet Res; 2009 Dec; 70(12):1512-20. PubMed ID: 19951123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation.
    Meije CB; Das PK; Jans MM; Hau C; van der Wal AC; Alders M; Hakvoort TB; Weidle UH; Lamers WH; Swart GW
    J Pathol; 2002 Aug; 197(5):668-76. PubMed ID: 12210088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression markers.
    Pós Z; Sáfrány G; Müller K; Tóth S; Falus A; Hegyesi H
    Cancer Res; 2005 May; 65(10):4458-66. PubMed ID: 15899839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
    Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cloning of the tag7 gene expressed in metastatic mouse tumors].
    Kustikova OS; Kiselev SL; Borodulina OR; Senin VM; Afanas'eva AV; Kabishev AA
    Genetika; 1996 May; 32(5):621-8. PubMed ID: 8755036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
    Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
    Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression.
    Francia G; Mitchell SD; Moss SE; Hanby AM; Marshall JF; Hart IR
    Cancer Res; 1996 Sep; 56(17):3855-8. PubMed ID: 8752144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
    Jaeger J; Koczan D; Thiesen HJ; Ibrahim SM; Gross G; Spang R; Kunz M
    Clin Cancer Res; 2007 Feb; 13(3):806-15. PubMed ID: 17289871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.
    Raybaud F; Noguchi T; Marics I; Adelaide J; Planche J; Batoz M; Aubert C; de Lapeyriere O; Birnbaum D
    Cancer Res; 1988 Feb; 48(4):950-3. PubMed ID: 3276402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
    Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
    Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of a novel melanoma tumor suppressor gene on human chromosome 6q21.
    Fung JM; Smith R; Brown MA; Lau SH; Xie D; Lau GK; Guan XY
    Clin Cancer Res; 2009 Feb; 15(3):797-803. PubMed ID: 19188149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of THW, a putative new tumor suppressor gene.
    Hildebrandt T; Preiherr J; Tarbé N; Klostermann S; Van Muijen GN; Weidle UH
    Anticancer Res; 2000; 20(5A):2801-9. PubMed ID: 11062687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.